Product Information
Registration Status: ActiveSIN03047P
MERISLON TABLET 6mg is approved to be sold in Singapore with effective from 1989-07-06. It is marketed by EISAI (SINGAPORE) PTE LTD, with the registration number of SIN03047P.
This product contains Betahistine 6mg in the form of TABLET. It is approved for ORAL use.
This product is manufactured by EISAI CO LTD in JAPAN.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière's disease. It is also commonly used for patients with balance disorders.
Indication
For the reduction of episodes of vertigo association with Ménière's disease.
Pharmacokinetics
- Absorption
- When given orally, betahistine is rapidly absorbed from the gastrointestinal tract.
- Distribution
- Metabolism
- Betahistine is metabolized primarily into 2-pyridylacetic acid and is subsequently excreted in the urine.
- Elimination
Toxicity
Symptoms of overdose ( 640 mg).
Active Ingredient/Synonyms
[2-(2-Pyridyl)ethyl]methylamine | 2-(beta-Methylaminoethyl)pyridine | 2-[2-(Methylamino)ethyl]pyridine | Betahistina | Betahistinum | N-Methyl-2-(2-pyridinyl)ethanamine | N-Methyl-2-pyridineethanamine | Betahistine |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.